Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Medicare AWP Payment Cut Takes Effect Jan. 1; Exemption Requests Due

Executive Summary

Manufacturers seeking an exemption from the new AWP minus 15% reimbursement formula for drugs covered under Medicare Part B must inform the Centers for Medicare & Medicaid Services by Jan. 1

You may also be interested in...



J&J Procrit Medicare Reimbursement Will Be 87% Of AWP Under Final Rule

Johnson & Johnson's Procrit will be reimbursed at 87% of average wholesale price under Medicare Part B in 2004, two percentage points higher than most drugs

J&J Procrit Medicare Reimbursement Will Be 87% Of AWP Under Final Rule

Johnson & Johnson's Procrit will be reimbursed at 87% of average wholesale price under Medicare Part B in 2004, two percentage points higher than most drugs

Medicare AWP Reform Plan May Be “Politically Untenable,” Amgen Says

The impact of Medicare's new oncology reimbursement policy will depend on how "average sales price" is defined, Amgen said

Latest Headlines
See All
UsernamePublicRestriction

Register

PS043033

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel